Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/166338
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vieira, Raquel | - |
dc.contributor.author | Souto, Selma B. | - |
dc.contributor.author | Sánchez-López, E. (Elena) | - |
dc.contributor.author | López-Machado, Ana | - |
dc.contributor.author | Severino, Patrícia | - |
dc.contributor.author | Jose, Sajan | - |
dc.contributor.author | Santini, Antonello | - |
dc.contributor.author | Fortiuna, Ana | - |
dc.contributor.author | García López, María Luisa | - |
dc.contributor.author | Silva, Amélia M. | - |
dc.contributor.author | Souto, Eliana B. | - |
dc.date.accessioned | 2020-06-19T14:32:20Z | - |
dc.date.available | 2020-06-19T14:32:20Z | - |
dc.date.issued | 2019-10-10 | - |
dc.identifier.issn | 1424-8247 | - |
dc.identifier.uri | http://hdl.handle.net/2445/166338 | - |
dc.description.abstract | Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia together with disturbances in the metabolism of carbohydrates, proteins and fat, which in general results from an insulin availability and need imbalance. In a great number of patients, marketed anti-glycemic agents have shown poor effectiveness in maintaining a long-term glycemic control, thus being associated with severe adverse effects and leading to an emerging interest in natural compounds (e.g., essential oils and other secondary plant metabolites, namely, flavonoid-rich compounds) as a novel approach for prevention, management and/or treatment of either non-insulin-dependent diabetes mellitus (T2DM, type 2 DM) and/or Metabolic Syndrome (MS). In this review, some of these promising glucose-lowering agents will be comprehensively discussed | - |
dc.format.extent | 31 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/ph12040152 | - |
dc.relation.ispartof | Pharmaceuticals, 2019, vol. 12, num. 4, p. 152 | - |
dc.relation.uri | https://doi.org/10.3390/ph12040152 | - |
dc.rights | cc-by (c) Vieira, Raquel et al., 2019 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) | - |
dc.subject.classification | Diabetis no-insulinodependent | - |
dc.subject.classification | Síndrome metabòlica | - |
dc.subject.classification | Fitoteràpia | - |
dc.subject.classification | Farmacologia | - |
dc.subject.classification | Glucèmia | - |
dc.subject.other | Non-insulin-dependent diabetes | - |
dc.subject.other | Metabolic syndrome | - |
dc.subject.other | Phytotherapy | - |
dc.subject.other | Pharmacology | - |
dc.subject.other | Blood sugar | - |
dc.title | Sugar-lowering drugs for type 2 Diabetes Mellitus and Metabolic Syndrome Review of cassical and new compounds: Part-I | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 701302 | - |
dc.date.updated | 2020-06-19T14:32:20Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 31658729 | - |
Appears in Collections: | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) Articles publicats en revistes (Institut de Nanociència i Nanotecnologia (IN2UB)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
701302.pdf | 1.21 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License